Autophagy in Huntington disease and huntingtin in autophagy

Trends in Neurosciences

Volumn 38, Issue 1, 2015, Pages 26-35

  Martin, Dale D O ^a   Ladha, Safia ^a   Ehrnhoefer, Dagmar E ^a   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Autophagy; Caspases; Huntington disease; Myristoylation; Neurodegeneration; Post translational modifications; Therapies; Trafficking

Indexed keywords

ADAPTOR PROTEIN; CASPASE 6; DYNEIN ADENOSINE TRIPHOSPHATASE; HUNTINGTIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; POLYGLUTAMINE; PROTEIN AGGREGATE; RECEPTOR PROTEIN; HTT PROTEIN, HUMAN; NERVE PROTEIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; CELL ORGANELLE; CELL STRESS; CHAPERONE-MEDIATED AUTOPHAGY; CYTOPLASM; ENZYME DEGRADATION; HUMAN; HUNTINGTON CHOREA; LYSOSOME; MACROAUTOPHAGY; MICROAUTOPHAGY; MYRISTYLATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REVIEW; SUMOYLATION; UBIQUITINATION; ANIMAL; METABOLISM; NERVE DEGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; AUTOPHAGY; HUMANS; HUNTINGTON DISEASE; NERVE DEGENERATION; NERVE TISSUE PROTEINS;

EID: 84922359207     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2014.09.003     Document Type: Review

References (115)

1. Novak M.J., Tabrizi S.J. Huntington's disease. BMJ 2010, 340:c3109.
2. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
3. Cortes C.J., La Spada A.R. The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy. Drug. Discov. Today 2014, 19:963-971.
4. Dragatsis I., et al. Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat. Genet. 2000, 26:300-306.
5. Zeitlin S., et al. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat. Genet. 1995, 11:155-163.
6. Nasir J., et al. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 1995, 81:811-823.
7. Duyao M.P., et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 1995, 269:407-410.
8. Kaushik S., et al. Autophagic pathways and metabolic stress. Diabetes Obes. Metab. 2010, 12(Suppl. 2):4-14.
9. Kon M., Cuervo A.M. Chaperone-mediated autophagy in health and disease. FEBS Lett. 2010, 584:1399-1404.
10. Nixon R.A. The role of autophagy in neurodegenerative disease. Nat. Med. 2013, 19:983-997.
11. Lemasters J.J. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res. 2005, 8:3-5.
12. Kraft C., et al. Mature ribosomes are selectively degraded upon starvation by an autophagy pathway requiring the Ubp3p/Bre5p ubiquitin protease. Nat. Cell Biol. 2008, 10:602-610.
13. Hanna R.A., et al. Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J. Biol. Chem. 2012, 287:19094-19104.
14. Isakson P., et al. The role of ALFY in selective autophagy. Cell Death Differ. 2012, 20:12-20.
15. Filimonenko M., et al. The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy. Mol. Cell 2010, 38:265-279.
16. Wong M. Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Biomed J. 2013, 36:40-50.
17. Wei Y., et al. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 2008, 30:678-688.
18. Williams A., et al. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 2008, 4:295-305.
19. Shaid S., et al. Ubiquitination and selective autophagy. Cell Death Differ. 2013, 20:21-30.
20. Jana N.R., Nukina N. BAG-1 associates with the polyglutamine-expanded huntingtin aggregates. Neurosci. Lett. 2005, 378:171-175.
21. Kalchman M.A., et al. Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. J. Biol. Chem. 1996, 271:19385-19394.
22. Steffan J.S., et al. SUMO modification of Huntingtin and Huntington's disease pathology. Science 2004, 304:100-104.
23. Mitra S., et al. Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease. J. Biol. Chem. 2009, 284:4398-4403.
24. Sieradzan K.A., et al. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein. Exp. Neurol. 1999, 156:92-99.
25. Waelter S., et al. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol. Biol. Cell 2001, 12:1393-1407.
26. Kirkin V., et al. A role for ubiquitin in selective autophagy. Mol. Cell 2009, 34:259-269.
27. Bennett E.J., et al. Global changes to the ubiquitin system in Huntington's disease. Nature 2007, 448:704-708.
28. Tydlacka S., et al. Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons. J. Neurosci. 2008, 28:13285-13295.
29. McKinnon C., Tabrizi S.J. The ubiquitin-proteasome system in neurodegeneration. Antioxid. Redox Signal. 2014, 10.1089/ars.2013.5802.
30. Li X., et al. Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments. Hum. Mol. Genet. 2010, 19:2445-2455.
31. Schipper-Krom S., et al. Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies. FEBS Lett. 2014, 588:151-159.
32. Tan J.M., et al. Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum. Mol. Genet. 2008, 17:431-439.
33. Butland S.L., et al. The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington's disease. Hum. Mol. Genet. 2014, 23:4142-4160.
34. Korac J., et al. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J. Cell Sci. 2013, 126:580-592.
35. Schwab C., et al. Optineurin in Huntington's disease intranuclear inclusions. Neurosci. Lett. 2012, 506:149-154.
36. Bjorkoy G., et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 2005, 171:603-614.
37. Tung Y.T., et al. The evolutionarily conserved interaction between LC3 and p62 selectively mediates autophagy-dependent degradation of mutant huntingtin. Cell. Mol. Neurobiol. 2010, 30:795-806.
38. Nagaoka U., et al. Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions. J. Neurochem. 2004, 91:57-68.
39. Pankiv S., et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 2007, 282:24131-24145.
40. Bartlett B.J., et al. p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects. Autophagy 2011, 7:572-583.
41. Menzies F.M., et al. Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Brain 2010, 133:93-104.
42. Wang Y., et al. Synergy and antagonism of macroautophagy and chaperone-mediated autophagy in a cell model of pathological tau aggregation. Autophagy 2010, 6:182-183.
43. Webb J.L., et al. Alpha-synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 2003, 278:25009-25013.
44. Menzies F.M., et al. Protein misfolding disorders and macroautophagy. Curr. Opin. Cell Biol. 2011, 23:190-197.
45. Kegel K.B., et al. Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J. Neurosci. 2000, 20:7268-7278.
46. Petersen A., et al. Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum. Mol. Genet. 2001, 10:1243-1254.
47. Martinez-Vicente M., et al. Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat. Neurosci. 2010, 13:567-576.
48. Ravikumar B., et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 2004, 36:585-595.
49. Wong Y.C., Holzbaur E.L. The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J. Neurosci. 2014, 34:1293-1305.
50. del Toro D., et al. Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus. Mol. Biol. Cell 2009, 20:1478-1492.
51. Elmore S.P., et al. The mitochondrial permeability transition initiates autophagy in rat hepatocytes. FASEB J. 2001, 15:2286-2287.
52. Kim I., et al. Selective degradation of mitochondria by mitophagy. Arch. Biochem. Biophys. 2007, 462:245-253.
53. Yano H., et al. Inhibition of mitochondrial protein import by mutant huntingtin. Nat. Neurosci. 2014, 17:822-831.
54. Rotblat B., et al. HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:3032-3037.
55. Koga H., et al. Constitutive upregulation of chaperone-mediated autophagy in Huntington's disease. J. Neurosci. 2011, 31:18492-18505.
56. Baldo B., et al. Maintenance of basal levels of autophagy in Huntington's disease mouse models displaying metabolic dysfunction. PLoS ONE 2012, 8:e83050.
57. Hodges A., et al. Regional and cellular gene expression changes in human Huntington's disease brain. Hum. Mol. Genet. 2006, 15:965-977.
58. Kuhn A., et al. Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain. Nat. Methods 2011, 8:945-947.
59. Ge D., et al. Identification of a novel MTOR activator and discovery of a competing endogenous RNA regulating autophagy in vascular endothelial cells. Autophagy 2014, 10:957-971.
60. Kamat P.K., et al. Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease. Cell Biochem. Biophys. 2014, 10.1007/s12013-014-0006-5.
61. Costa V., et al. Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli. EMBO Mol. Med. 2010, 2:490-503.
62. Metzger S., et al. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients. PLoS ONE 2013, 8:e68951.
63. Heng M.Y., et al. Early alterations of autophagy in Huntington disease-like mice. Autophagy 2010, 6:1206-1208.
64. Maday S., et al. Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons. J. Cell Biol. 2012, 196:407-417.
65. Ravikumar B., et al. Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat. Genet. 2005, 37:771-776.
66. Hinckelmann M-V.V., et al. Releasing the brake: restoring fast axonal transport in neurodegenerative disorders. Trends Cell Biol. 2013, 23:634-643.
67. Martin D.D., et al. Identification of a post-translationally myristoylated autophagy-inducing domain released by caspase cleavage of Huntingtin. Hum. Mol. Genet. 2014, 23:3166-3179.
68. Atwal R.S., et al. Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum. Mol. Genet. 2007, 16:2600-2615.
69. Farazi T.A., et al. The biology and enzymology of protein N-myristoylation. J. Biol. Chem. 2001, 276:39501-39504.
70. Martin D.D., et al. Post-translational myristoylation: fat matters in cellular life and death. Biochimie 2011, 93:18-31.
71. Martin D.D., et al. Tandem reporter assay for myristoylated proteins post-translationally (TRAMPP) identifies novel substrates for post-translational myristoylation: PKCepsilon, a case study. FASEB J. 2012, 26:13-28.
72. Steffan J.S. Does Huntingtin play a role in selective macroautophagy?. Cell Cycle 2010, 9:3401-3413.
73. Fan W., et al. Autophagosome targeting and membrane curvature sensing by Barkor/Atg14(L). Proc. Natl. Acad. Sci. U.S.A. 2011, 108:7769-7774.
74. Kalvari I., et al. iLIR: A web resource for prediction of Atg8-family interacting proteins. Autophagy 2014, 10:913-925.
75. Ehrnhoefer D.E., et al. Mouse models of Huntington disease: variations on a theme. Dis. Model Mech. 2009, 2:123-129.
76. Graham R.K., et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 2006, 125:1179-1191.
77. Ehrnhoefer D.E., et al. Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease. Neuroscientist 2011, 17:475-492.
78. Bhat K.P., et al. Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:5706-5711.
79. Wong E., et al. Molecular determinants of selective clearance of protein inclusions by autophagy. Nat. Commun. 2012, 3:1240.
80. Gu X., et al. Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron 2009, 64:828-840.
81. Thompson L.M., et al. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J. Cell Biol. 2009, 187:1083-1099.
82. Jia H., et al. Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems. Hum. Mol. Genet. 2012, 21:5280-5293.
83. Mielcarek M., et al. SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease. PLoS ONE 2011, 6:e27746.
84. Mielcarek M., et al. HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration. PLoS Biol. 2013, 11:e1001717.
85. Jeong H., et al. Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 2009, 137:60-72.
86. Marino G., et al. Self-consumption: the interplay of autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 2014, 15:81-94.
87. Rubinstein A.D., Kimchi A. Life in the balance - a mechanistic view of the crosstalk between autophagy and apoptosis. J. Cell Sci. 2012, 125:5259-5268.
88. Li Z., et al. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell 2010, 141:859-871.
89. Hyman B.T., Yuan J. Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology. Nat. Rev. Neurosci. 2012, 13:395-406.
90. Cusack C.L., et al. Distinct pathways mediate axon degeneration during apoptosis and axon-specific pruning. Nat. Commun. 2013, 4:1876.
91. Erturk A., et al. Local pruning of dendrites and spines by caspase-3-dependent and proteasome-limited mechanisms. J. Neurosci. 2014, 34:1672-1688.
92. Olsen O., et al. Genetic analysis reveals that amyloid precursor protein and death receptor 6 function in the same pathway to control axonal pruning independent of beta-secretase. J. Neurosci. 2014, 34:6438-6447.
93. Hara T., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441:885-889.
94. Komatsu M., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441:880-884.
95. Lee S., et al. Primary lysosomal dysfunction causes cargo-specific deficits of axonal transport leading to Alzheimer-like neuritic dystrophy. Autophagy 2011, 7:1562-1563.
96. Yue Z. Regulation of neuronal autophagy in axon: implication of autophagy in axonal function and dysfunction/degeneration. Autophagy 2007, 3:139-141.
97. Shehata M., Inokuchi K. Does autophagy work in synaptic plasticity and memory?. Rev. Neurosci. 2014, 25:543-557.
98. Graham R.K., et al. Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo. J. Neurosci. 2010, 30:15019-15029.
99. Gafni J., et al. Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment. J. Neurosci. 2012, 32:7454-7465.
100. Norman J.M., et al. The in vitro cleavage of the hAtg proteins by cell death proteases. Autophagy 2010, 6:1042-1056.
101. Graham R.K., et al. Caspase-6 and neurodegeneration. Trends Neurosci. 2011, 34:646-656.
102. Tiwari M., et al. A nonapoptotic role for CASP2/caspase 2: Modulation of autophagy. Autophagy 2014, 10:1054-1070.
103. Jiang P., Mizushima N. Autophagy and human diseases. Cell Res. 2014, 24:69-79.
104. Eschbach J., Dupuis L. Cytoplasmic dynein in neurodegeneration. Pharmacol. Ther. 2011, 130:348-363.
105. Sarkar S. Chemical screening platforms for autophagy drug discovery to identify therapeutic candidates for Huntington's disease and other neurodegenerative disorders. Drug Discov. Today Technol. 2013, 10:e137-e144.
106. Sarkar S., et al. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ. 2009, 16:46-56.
107. Klionsky D.J., et al. A comprehensive glossary of autophagy-related molecules and processes (2nd edition). Autophagy 2011, 7:1273-1294.
108. Korac J., et al. Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J. Cell Sci. 2013, 126:580-592.
109. Lemaire K., et al. Ubiquitin fold modifier 1 (UFM1) and its target UFBP1 protect pancreatic beta cells from ER stress-induced apoptosis. PLoS ONE 2011, 6:e18517.
110. Alers S., et al. The incredible ULKs. Cell Commun. Signal. 2011, 10:7.
111. Zhang Y., et al. Regulation of p53 level by UBE4B in breast cancer. PLoS ONE 2014, 9:e90154.
112. Huang K., et al. Wild-type HTT modulates the enzymatic activity of the neuronal palmitoyl transferase HIP14. Hum. Mol. Genet. 2011, 20:3356-3365.
113. Rampoldi F., et al. A new, robust, and nonradioactive approach for exploring N-myristoylation. J. Lipid Res. 2012, 53:2459-2468.
114. Perinpanayagam M.A., et al. Regulation of co- and post-translational myristoylation of proteins during apoptosis: interplay of N-myristoyltransferases and caspases. FASEB J. 2013, 27:811-821.
115. LeBlanc A.C. Caspase-6 as a novel early target in the treatment of Alzheimer's disease. Eur. J. Neurosci. 2013, 37:2005-2018.